Could tear endothelin-1 levels be associated with disability in multiple sclerosis?
dc.contributor.author | Cam, Mustafa | |
dc.contributor.author | Sehitoglu, Hilal | |
dc.date.accessioned | 2025-01-27T20:45:56Z | |
dc.date.available | 2025-01-27T20:45:56Z | |
dc.date.issued | 2023 | |
dc.department | Çanakkale Onsekiz Mart Üniversitesi | |
dc.description.abstract | Background: Endothelin-1 (ET-1) is a potent vasoconstrictor substance mainly secreted by endothelial cells. Increased ET-1 levels in plasma or cerebrospinal fluid (CSF) have been identified in multiple sclerosis (MS). We aimed to analyze tear ET-1 levels; visual evoked potential (VEP) and disability scores in patients with MS and in healthy controls. Methods: Adult patients (18-65 year-old) diagnosed with MS according to the McDonald criteria, and healthy controls were recruited for the study. Demographic features, VEP, and tear ET-1 levels were evaluated. Disability in the MS group was assessed and grouped by EDSS score (<3 vs. >= 3). The EDSS score in healthy controls was zero. Results: Both in the total number of patients overall and in the patients with EDSS score <3, tear ET-1 levels were higher in the MS group than that in the controls (p<0.001). In the MS group, the ET-1 level was higher in the patients with EDSS score >= 3 than in those with EDSS score <3 (p<0.001). The tear ET-1 level was positively correlated with age and EDSS score in the MS group (p<0.001). Conclusion: To the best of our knowledge, there is no study in the literature that measures tear ET-1 levels in MS and examines their relationship with EDSS score and VEP. Higher tear ET-1 levels seem to be associated with disability and abnormal VEP in MS. Tear ET-1 measurement may be a simple new noninvasive marker indicating the disability in the patients with MS in the future. | |
dc.identifier.doi | 10.54029/2023itk | |
dc.identifier.endpage | 701 | |
dc.identifier.issn | 1823-6138 | |
dc.identifier.issue | 3 | |
dc.identifier.scopus | 2-s2.0-85173253722 | |
dc.identifier.scopusquality | Q4 | |
dc.identifier.startpage | 695 | |
dc.identifier.uri | https://doi.org/10.54029/2023itk | |
dc.identifier.uri | https://hdl.handle.net/20.500.12428/24767 | |
dc.identifier.volume | 28 | |
dc.identifier.wos | WOS:001085393800025 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.language.iso | en | |
dc.publisher | Asean Neurological Assoc | |
dc.relation.ispartof | Neurology Asia | |
dc.relation.publicationcategory | info:eu-repo/semantics/openAccess | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_WoS_20250125 | |
dc.subject | Endothelin | |
dc.subject | multiple sclerosis | |
dc.subject | EDSS | |
dc.subject | VEP | |
dc.subject | endothelin 1. | |
dc.title | Could tear endothelin-1 levels be associated with disability in multiple sclerosis? | |
dc.type | Article |